financetom
Business
financetom
/
Business
/
Roche continues to look for obesity assets after Carmot deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Roche continues to look for obesity assets after Carmot deal
Jul 24, 2024 11:24 PM

FRANKFURT, July 25 (Reuters) - Roche's CEO said

the Swiss company is looking into potentially acquiring further

obesity drug development assets even after the $2.7 billion

Carmot Therapeutics takeover, agreed in December.

Speaking in a media call after the release of first-half

results, CEO Thomas Schinecker also said that 25% of projects in

the group's drug development pipeline had been stopped over the

last 12 months to shift resources to the most promising

projects. He took the helm in March 2023.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved